Advanced Cancer

Disease

Related News

FDA Grants Fast Track Designation to Pasithea's PAS-004 for NF1-Associated Tumors

The FDA has granted Fast Track designation to Pasithea Therapeutics' PAS-004 for treating NF1-associated plexiform neurofibromas. The designation facilitates expedited development and review for serious conditions with unmet medical needs. Pasithea is currently conducting Phase 1/1b trials of the next-generation MEK inhibitor in patients with these tumors.

Immunotherapy Expands to Earlier Cancer Stages Across Multiple Tumor Types

Immunotherapy is increasingly used in earlier cancer stages before or after surgery across seven tumor areas. Research shows neoadjuvant and adjuvant immunotherapy can reduce recurrence risk and improve immune recognition of tumor cells. However, challenges remain including side effects, costs, and determining which patients benefit most from earlier treatment.

Related Clinical Trials

NCT ID Title Status Phase
NCT07761988

The FamilyStrong Pilot Randomized Trial

NOT_YET_RECRUITING NA
NCT07737899

Primary Palliative Care - a Feasibility Cluster Trial

NOT_YET_RECRUITING NA
NCT07712237

Web-Based Advance Care Planning for Patients With Advanced Cancer

COMPLETED NA
NCT07659158

Virtual Group Resilient Living Program For Patients Living With Advanced Cancer

RECRUITING NA
NCT07654933

Physiotherapy Effects on Function, Ambulation, and Independence in Palliative Cancer Care

COMPLETED NA
NCT07648160

Contrast-enhanced CBCT With C-arm HyperSight Technology

RECRUITING NA
NCT07644533

Electroacupuncture for Preventing Chemotherapy-Induced Peripheral Neuropathy in Patients With Advanced Cancer

NOT_YET_RECRUITING NA
NCT07636382

Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy in Patients With Cancer-Related Celiac Pain

RECRUITING NA
NCT07605962

Phase 1/2 Study of UI-102 in Selected Advanced Cancers

RECRUITING PHASE1/PHASE2
NCT07540468

Safety Evaluation of Bioactive Glass Based Bone Cement Combined With Ultrasound in Implantation for Metastatic Bone Tumors

NOT_YET_RECRUITING NA